David Wallace

David Wallace is a seasoned professional in the field of intellectual property and scientific consulting, currently serving as Senior Director of Intellectual Property at Biosplice Therapeutics since July 2013. At Biosplice, Wallace focuses on developing innovative small-molecule therapeutics linked to alternative pre-mRNA splicing. Additionally, as President and Founder of Wallace Scientific Consulting since 2005, Wallace offers expertise in organic and medicinal chemistry, project management, and patent-related services. Previous roles include serving as a Network Partner at TRN - The Research Network Ltd and various consulting positions at companies such as Cyanotech Corporation, Rempex Pharmaceuticals, and Samumed, where responsibilities included managing chemistry IP portfolios and conducting patent searches. David Wallace holds a Ph.D. in Organic Chemistry from the University of California, Davis, and a Bachelor of Science in Chemistry from Wright State University.